Combination of guanine arabinoside and Bcl-2 inhibitor YC137 overcomes the cytarabine resistance in HL-60 leukemia cell line-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Combination of guanine arabinoside and Bcl-2 inhibitor YC137 overcomes the cytarabine resistance in HL-60 leukemia cell line

Published:2013-02-24 Issue:4 Volume:104 Page:502-507
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Nishi Rie¹,Yamauchi Takahiro¹,Negoro Eiju¹,Takemura Haruyuki¹,Ueda Takanori¹

Affiliation:

1. Department of Hematology and Oncology; Faculty of Medical Sciences; University of Fukui; Eiheiji; Fukui; Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cas.12103/fullpdf

Reference41 articles.

1. Nucleoside analogues: mechanisms of drug resistance and reversal strategies;Galmarini;Leukemia,2001

2. Unanswered questions in acute myeloid leukemia;Ferrara;Lancet Oncol,2004

3. Drug therapy for acute myeloid leukemia;Tallman;Blood,2005

4. Adult acute myeloid leukemia;Jabbour;Mayo Clin Proc,2006

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Galectin-9 has non-apoptotic cytotoxic activity toward acute myeloid leukemia independent of cytarabine resistance;Cell Death Discovery;2023-07-06

2. Galectin-9 has non-apoptotic cytotoxic activity towards Acute Myeloid Leukemia independent of cytarabine resistance;2023-02-02

3. Galectin-9 has non-apoptotic cytotoxic activity towards Acute Myeloid Leukemia independent of cytarabine resistance;2023-01-14

4. Inhibition of Autophagy Does Not Re-Sensitize Acute Myeloid Leukemia Cells Resistant to Cytarabine;International Journal of Molecular Sciences;2021-02-26

5. Venetoclax and alvocidib are both cytotoxic to acute myeloid leukemia cells resistant to cytarabine and clofarabine;BMC Cancer;2020-10-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3